Searchable abstracts of presentations at key conferences in endocrinology

ea0006p39 | Endocrine tumours and neoplasia | SFE2003

Use of Continous glucose monitoring system in the medical management of insulinomas

Baldeweg S , Hope S , Tibbals J , Davidson B , Vanderpump M

The continuous glucose monitoring system (CGMS) have recently been developed for use in diabetes to provide comprehensive blood glucose data around the clock during normal activities. We have demonstrated for the first time that CGMS can assist in the management of 2 patients with confirmed insulinomas. We present 2 female patients (aged 41 and 35 years) with symptoms suggestive of hypoglycaemia. Both had biochemical evidence of insulinoma with hypoglycaemia, hyperinsulinaemia...

ea0006dp23 | Diabetes, metabolism and cardiovascular | SFE2003

Use of Continous glucose monitoring system in the medical management of insulinomas

Baldeweg S , Hope S , Tibbals J , Davidson B , Vanderpump M

The continuous glucose monitoring system (CGMS) have recently been developed for use in diabetes to provide comprehensive blood glucose data around the clock during normal activities. We have demonstrated for the first time that CGMS can assist in the management of 2 patients with confirmed insulinomas. We present 2 female patients (aged 41 and 35 years) with symptoms suggestive of hypoglycaemia. Both had biochemical evidence of insulinoma with hypoglycaemia, hyperinsulinaemia...

ea0091cb2 | Additional Cases | SFEEU2023

Subclinical hyperthyroidism in pregnancy

Hope David

33 year old female who is 5 months pregnant, referred to Endocrinology clinic with TFT’s in keeping with sub clinical hyperthyroidism. Previously also had thyroid USS showing large 5 cm nodules both lobes, both indeterminate in appearance (U3) which preceded pregnancy. Symptomatic with sweating and palpitations. No family history of thyroid disease and no ‘red flag’ symptoms. Clinical examination showed palpable thyroid nodules with no evidence of thyrotoxicosis...

ea0070s6.3 | Adrenocortical carcinoma | ECE2020

ACC - what’s new today; where is hope tomorrow

Hammer Gary

Adrenocortical Carcinoma (Adrenal Cancer or ACC) is a rare malignancy. It requires multidisciplinary care to manage the multiple endocrine and oncologic manifestations of the disease. We will use the recently published international ACC Guidelines to illustrate essential components of the standard of care work-up, diagnosis, and management of ACC. As an understanding of genetics is becoming increasingly mainstream in cancer biology and care including adrenocortical carcinoma (...

ea0022p31 | Adrenal | ECE2010

Adrenocortical cancer: any hope? case reports

Valkusz Zsuzsanna , Magony Sandor , Csajbok Eva , Gardi Janos , Kiss Ildiko , Julesz Janos

Adrenocortical cancer is a rare and heterogenous malignancy with incompletely understood pathogenesis and poor prognosis. Sometimes patients present with hormonal excess symptoms (e.g. virilization, Cushing’s syndrome) or local symptoms consistent with abdominal space-occupation (median tumor size at the time of diagnosis may be >10 cm). Three cases are presented to give an overview of how adrenocortical cancer is currently managed. Tumors typically appear inhomogenou...

ea0078dpd1.1 | Session 1 | BSPED2021

Low Carbohydrate Diets in Type 2 Diabetes: Drug-free remission and hope

Unwin David

Dr David Unwin MbChB FRCGP Our GP practice of 9500 people has suffered an eight-fold increase in the number of patients with T2D since 1986. In addition, those affected now develop this condition decades earlier than was the norm back in 1986. A situation replicated all over the developed world. Nationally there are 122,780 children and young adults under the age of 40 years with type 2 diabetes, 1,560 (around 1.3 per cent) are under the age of 19 years. In 2013 our practice d...

ea0014p583 | (1) | ECE2007

The endocrine and behavioural actions of neuromedine S

Jászberényi Miklós , Bagosi Zsolt , Szabó Gyula , Telegdy Gyula

Since earlier publications revealed a prominent and versatile impact of the neuromedin peptide family on several neuroendocrine processes, in the present experiments we focused on the effects of a recently discovered member of neuromedines, neuromedine S on such phenomena as open-field behaviour and hypothalamic-pituitary-adrenal (HPA) activation. The peptide was administered intracerebroventricularly to freely moving rats and 30 minutes later the aforementioned neuronedocrine...

ea0011p98 | Clinical case reports | ECE2006

Hypocalcemic cardiomyopathy in a patient with primary hypoparathyroidism and Fahr’s disease

Azzoug S , Chentli F

Hypocalcemic cardiomyopathy due to hypoparathyroidism is a very rare condition which responds favorably to vitaminocalcic treatment.We report the case of a 50 years old man who presented to our unit for general fatigue, apathy and cough lasting several years with a worsening during the last months, there was biological evidence of hypoparathyroidism with profound hypocalcemia (21 mg/l) hyperphosphoremia (53 mg/l) and undetectable PTH levels the CT scan s...

ea0011p600 | Neuroendocrinology and behaviour | ECE2006

Pulmonary function in Cushing’s disease

Bayraktaroglu T , Kutluturk F , Turan E , Orhan Y , Tanyolac S

Numerous clinical manifestations have been described in association with Cushing’s disease (CD). There was no eligible data on pulmonary function tests in CD patients. We aimed to assess pulmonary function test included spirometry in a series of patients with active Cushing’s disease (2 men, 9 women). Mean age, height, weight, body mass index were 36.7±12.6 (range 22–63 years), 156.9±8.4 cm, 74.1±10.7 kg, 29.6±3.8 kg/m2, respective...

ea0077p62 | Metabolism, Obesity and Diabetes | SFEBES2021

Hypoglycaemia in non-diabetics. An Endocrinologist’s perspective

Sharaf Giselle , Bhagi Ridhi , Morgan Georgia , Cozma S. Lawrence , Roy Chowdhury Sharmistha

Hypoglycaemia, a life threatening complication, occurs as part of a wide variety of disease processes. Though a common side effect of diabetes medications, it can be secondary to other factors including, endocrine and, metabolic disorders, severe sepsis, rare malignancies and non-diabetic medications. We present a case series of 3 non-diabetic patients who presented to Princess of Wales, Bridgend with Hypoglycaemic Episodes (HE):1. 23 year old student nu...